Details for 2018169756
Up to date per 21.04.2026
Actions
Details for 2018169756
Granted/Registered
European Patent
12.09.2018 A
23.09.2020 B1
19.12.2014
US
201462094436 P
C07D 213/84 20060101AFI20180531BHEP
Owner
Aragon Pharmaceuticals, Inc.10990 Wilshire Blvd. Suite 300 Los Angeles, CA 90024US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
BEN HAIM, CyrilKoolhof 6 Bus 08 2350 VosselaarBE
HORVATH, AndrasSmalvoortstraat 46 Bus 2 B2300 TurnhoutBE
WEERTS, Johan Erwin EdmondStatiestraat 7 2340 BeerseBE
Information about Fees